Streetbeat News

Stock Prices

WBA

Walgreens Boots Alliance (WBA) reported strong Q4 FY2024 sales of $37.55 billion, surpassing expectations. The company plans to close 1,200 stores by 2027, with 500 closures in FY2025, to boost EPS and cash flow. Analysts maintain a Hold rating with a price target of $10.

Portfolio Pulse from Vandana Singh

October 16, 2024 | 6:48 pm

ML

MoneyLion shares rose after Northland Capital Markets initiated coverage with an Outperform rating and a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 6:45 pm

EA

Electronic Arts Inc (NASDAQ:EA) is shutting down Plants vs. Zombies 3 servers for a major overhaul, halting downloads and in-app purchases. The game will be inaccessible from Nov. 15, 2024. EA plans to preserve some account aspects but will reset game progress. The game has struggled to match the success of its predecessors.

Portfolio Pulse from Franca Quarneti

October 16, 2024 | 6:35 pm

NFLX

Netflix Inc (NASDAQ:NFLX) is set to report its Q3 earnings, with Wall Street expecting $5.12 EPS and $9.77 billion in revenues. The stock has risen significantly over the past year but currently shows a mixed technical outlook. Analysts maintain a 'Buy' rating with a slight upside potential.

Portfolio Pulse from Surbhi Jain

October 16, 2024 | 6:35 pm

BHRB

DA Davidson analyst Manuel Navas initiated coverage on Burke & Herbert Financial Services (NASDAQ:BHRB) with a Buy rating and a price target of $76, citing its underappreciated earnings potential and strong growth forecasts. The analyst highlights robust loan growth and repricing opportunities that could enhance the company's valuation.

Portfolio Pulse from Nabaparna Bhattacharya

October 16, 2024 | 6:32 pm

EYPT

EyePoint Pharmaceuticals shares rose after Scotiabank initiated coverage with a Sector Outperform rating and set an $18 price target.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 6:32 pm

JNJ

Johnson & Johnson (JNJ) reported a Q3 adjusted EPS of $2.42, beating expectations despite a 9% decline year-over-year. Sales rose 5.2% to $22.47 billion. The company updated its 2024 EPS guidance, factoring in the V-Wave acquisition. BofA Securities maintains a Neutral rating with a $170 price target, noting strong performance in oncology and potential challenges in the MedTech segment due to market pressures and litigation uncertainties.

Portfolio Pulse from Vandana Singh

October 16, 2024 | 6:31 pm

BN

Brookfield (NYSE:BN) has outperformed the market over the past 10 years with an average annual return of 12.75%, surpassing the market by 1.14% annually. A $100 investment in BN stock 10 years ago would now be worth $338.17.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 6:30 pm

FCNCA

First Citizens BancShares (NASDAQ:FCNCA) has significantly outperformed the market over the past 5 years, with an average annual return of 32.93%. A $1000 investment in FCNCA 5 years ago would now be worth $4,198.21, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 6:30 pm

ANF

Abercrombie & Fitch (NYSE:ANF) has seen a 9.48% increase in its short percent of float, now at 15.24%. This indicates a bearish sentiment among investors, although it is below the peer group average of 17.21%. Short interest can be a key indicator of market sentiment.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 6:30 pm